• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Biosckin

Biosckin

Molecular and Cell Therapies, S.A

  • Biosckin
  • Regenerative Medicine
    and Tissue Engineering
    • Cell therapies
    • Biomaterials
  • Products & Services
    • Covid-19 Products
    • Tests of Cyto and Biocompatibility
    • Cryopreservation of stem cells
    • Bonelike by Biosckin®
    • Flow cytometry
    • Growth factors from umbilical cord blood and dental pulp – CELLSECRET®
  • ID&I Nucleus
    • Projects
  • Contact us
  • English
  • Portuguese (Portugal)
Está aqui: Home / ID&I Nucleus

ID&I Nucleus

According to the strategic technological framework defined by Biosckin, in 2008 the Research, Development & Innovation (IDI) nucleus, called BioMat&Cell, was created.

The creation of Biosckin’s RDI nucleus allowed the company to develop internal research and development and innovation management skills in the company, through the creation of a structured unit with permanence characteristics and dedicated exclusively to industrial research and experimental development activities in area of ​​Regenerative Medicine and Cell Therapy, areas in which Biosckin intends to be a European reference.

The RDI core is adjusted to the company’s innovation policy in relation to the two areas of intervention. The first area carries out work in the development of new Biomaterials and the second, in the development of Cellular Therapies using stem cells from umbilical cord blood and umbilical cord tissue. Since April 2012, the RDI core has been considering certification by NP 4457.

The elements that are assigned to RDI activities have curricular profiles appropriate to the area of ​​activity of the nucleus, with the team consisting of doctorates and masters.

The company has several connections with Portuguese Universities, protocols and contracts with companies, international collaborations and several research partnerships.

These partnerships allow the formation of a multidisciplinary team in the area of ​​Regenerative Medicine and all are based on formal protocols that are independent of the shareholder structure and that give Biosckin an enormous capacity for technological updating and scientific advancement.

See our projects

Breaking News

PrintONorgans – Direct Biomanufacturing on Organs
Biosckin distinguida como PME Líder
Biosckin celebra parceria exclusiva com laboratório pioneiro na área de genética
Biosckin – laboratório Criovida tem protocolo científico com a Universidade do Porto desde 2007
Número crescente de aplicações clínicas das células estaminais do sangue do cordão umbilical
Biosckin, 10 anos de experiência e rigor
Grande potencial terapêutico das células estaminais do tecido do cordão umbilical em doenças do sistema imunológico
Biosckin no Projecto Inovação Portugal
Utilização de células estaminais do tecido do cordão umbilical na regeneração de lesões de nervo periférico
O avanço da utilização de células estaminais autólogas na área da medicina regenerativa
Uso do sangue do cordão umbilical em crianças com paralisia cerebral
Slider

Footer

Contacts

Biosckin, Molecular and Cell Therapies, S.A.

Tecmaia – Parque de Ciência e Tecnologia da Maia
Rua Engenheiro Frederico Ulrich, 2650
4470-605 – Moreira da Maia
Portugal

Telephone: (+351) 220 915 495
(+351) 220 915 498
Fax: (+351) 229 428 206

E-Mail: info@biosckin.com

  • LinkedIn

Sitemap

  • Biosckin
  • Regenerative Medicine and Tissue Engineering
  • Products & Services
  • ID&I Nucleus
  • News
  • Privacy Policy

Co-financing

Portuguese laboratory duly authorized by the Portuguese Authorities, the Directorate-General of Health

COPYRIGHT © 2021 BIOSCKIN · POWERED BY ACLSI